Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.

Oncogene
Leah A GatesCharles E Foulds

Abstract

Approximately 75% of breast cancers are estrogen receptor alpha (ERα)-positive and are treatable with endocrine therapies, but often patients develop lethal resistant disease. Frequent mutations (10-40%) in the ligand-binding domain (LBD) codons in the gene encoding ERα (ESR1) have been identified, resulting in ligand-independent, constitutively active receptors. In addition, ESR1 chromosomal translocations can occur, resulting in fusion proteins that lack the LBD and are entirely unresponsive to all endocrine treatments. Thus, identifying coactivators that bind to these mutant ERα proteins may offer new therapeutic targets for endocrine-resistant cancer. To define coactivator candidate targets, a proteomics approach was performed profiling proteins recruited to the two most common ERα LBD mutants, Y537S and D538G, and an ESR1-YAP1 fusion protein. These mutants displayed enhanced coactivator interactions as compared to unliganded wild-type ERα. Inhibition of these coactivators decreased the ability of ESR1 mutants to activate transcription and promote breast cancer growth in vitro and in vivo. Thus, we have identified specific coactivators that may be useful as targets for endocrine-resistant breast cancers.

References

Jul 31, 2004·Molecular Endocrinology·Meiyun FanKenneth P Nephew
Apr 11, 2006·The Journal of Biological Chemistry·Rigen MoYi-Jun Zhu
Oct 3, 2006·Nature Genetics·Jason S CarrollMyles Brown
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suleiman Massarweh, Rachel Schiff
Feb 12, 2008·Current Protocols in Molecular Biology·Susan M AbmayrJerry L Workman
Dec 3, 2009·Molecular Endocrinology·Jamie Bonéy-MontoyaAnn M Nardulli
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W Fraser SymmansLajos Pusztai
Oct 5, 2010·Annual Review of Medicine·C Kent Osborne, Rachel Schiff
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Lei ShiYongfeng Shang
Apr 17, 2012·The Journal of Clinical Investigation·Weiwen LongBert W O'Malley
May 1, 2012·Molecular Endocrinology·Kwang Won JeongMichael R Stallcup
Nov 5, 2013·Nature Genetics·Dan R RobinsonArul M Chinnaiyan
Nov 5, 2013·Nature Genetics·Weiyi ToySarat Chandarlapaty
Dec 18, 2013·Science·Tim WangEric S Lander
Jan 9, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rinath JeselsohnVincent A Miller
Jan 18, 2014·Endocrine-related Cancer·Kathleen Van AstenRobert Paridaens
Mar 5, 2014·The Breast : Official Journal of the European Society of Mastology·Eva CiruelosHernán Cortes-Funes
Dec 23, 2014·International Journal of Cancer. Journal International Du Cancer·Sonja ThalerJonathan P Sleeman
Mar 31, 2015·Breast Cancer Research and Treatment·Guowei GuSuzanne A W Fuqua
May 21, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suzanne E WardellShunqiang Li
Apr 17, 2016·Proceedings of the National Academy of Sciences of the United States of America·Xianzhou SongJin Wang
May 15, 2016·Breast Cancer Research and Treatment·Luca GelsominoSuzanne A W Fuqua
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charlotte FribbensNicholas C Turner

❮ Previous
Next ❯

Citations

Jul 19, 2019·Cancer·Derek DustinSuzanne A W Fuqua
Oct 10, 2019·American Journal of Physiology. Cell Physiology·Natasha ChernisSean M Hartig
Jun 4, 2019·Endocrinology·Malachi A Blundon, Subhamoy Dasgupta
Sep 17, 2020·Cells·Sarah A JeffreysTherese M Becker
Nov 26, 2020·International Journal of Molecular Sciences·Nuri LeeSeri Jeong
Dec 17, 2020·Oncogene·Guowei GuSuzanne A W Fuqua
Dec 8, 2020·Endocrinology·Anca M FarcasJason S Carroll
Apr 15, 2020·Cancer Cell·Ariella B HankerCarlos L Arteaga
Mar 21, 2021·Nature Communications·Liliana Garcia-MartinezLluis Morey
May 6, 2021·International Journal of Molecular Sciences·Licen LiQiang Chen
Jun 23, 2021·Biochemical Society Transactions·Lan-Hsin WangShu-Ping Wang
Aug 3, 2021·Expert Review of Anticancer Therapy·Marcelle GoldnerNoam Pondé
Oct 9, 2021·British Journal of Cancer·Sarah K Herzog, Suzanne A W Fuqua

❮ Previous
Next ❯

Datasets Mentioned

BETA
PXD005887
AZD9496
GDC0180

Methods Mentioned

BETA
pulldown
xenograft
co-immunoprecipitations
immunoprecipitation
ChIP
PCR

Clinical Trials Mentioned

NCT02248090
NCT03236974
NCT01142401

Software Mentioned

Image J
CompuSyn
Matlab
Calcusyn
KM plotter

Related Concepts